Latest AusBiotech News | Page 6

Patent granted in India and Notice of Allowance Issued in Israel for CLTX Car Technology
Carina Biotech to present details of planned trial of CAR-T cell therapy candidate
Opportunity to invest in Australian biotech companies
New approval for trial of Immutep’s ‘efti’ with Merck’s PD-L1 inhibitor
Cytiva supports BioCina with first GMP production and development facility for mRNA
Find and be found: Utilising free global life sciences Directory
Telix reports its first quarter of $100 million in revenue
Major milestone for Australian pharmaceutical company, Neuren
Regulatory changes for medical device clinical trials not needed
Proto Axiom invests in University of Sydney spin-out, EndoAxiom
Assessors needed for industry PhD program
Cynata receives ethics approval for proposed aGvHD Phase 2 clinical trial
Pharmaxis adds combination arm to PXS‐5505 myelofibrosis study
Focus turns to all things medtech
Immutep announces changes to its board of directors
Recce Pharmaceuticals announces planned grant of ‘Patent Family 4’ for anti-infectives
ATSE seek views on commercialisation
Emyria and Aspen Australia sign binding licensing and commercialisation term sheet
Pitch your early-stage medtech
Industry groups welcome Senate backing of National Reconstruction Fund
IDT achieves milestone with TGA-approved expansion of manufacturing
Radiopharm Theranostics and GenesisCare partner on development of radiopharmaceutical
AusMedtech goes back to future
Chimeric Therapeutics reports ‘positive feedback’ on plan for CHM 2101
Directory of Australian accelerators and incubators launched
Brandon BioCatalyst with ANDHealth to deliver BioMedTech Incubator Program
Support for passage of NRF legislation through Senate
Interim analysis shows accuracy of Optiscan Imaging platform
Proteomics says it will resubmit PromarkerD predictive test for Medicare funding
Patrys’ says preclinical data supports synthetic lethality mechanism
Call for speakers for biggest week in biotech
Immutep announces initiation of new breast cancer trial
Mark Butler announces funding for mitochondrial donation pilot program
National Reconstruction Fund moves closer to reality
FDA grants ‘orphan’ designation to PTX-100 for broader TCL indications
Chimeric Therapeutics advances manufacture of CHM 2101 viral vector
Biotech stocks back on road to recovery, according to latest report
Emyria partners with specialist trauma psychiatric service to advance MDMA-assisted therapy
GreenLight Clinical and Cure Therapeutics look to future collaboration
Starpharma announces appointment of chief financial officer
Embracing equity in life sciences sector
Microba Life Sciences announces new distribution agreements in Europe
Neuren Pharmaceuticals appoints experienced industry executive to board
Australian Cell and Gene Catalyst takes step forward
Incannex launches new trial assessing IHL-675A in rheumatoid arthritis
CSL reports positive results from pivotal late-stage trial of first-in-class garadacimab
AusBiotech to propose overhaul of TGA funding
TGA provisionally approves Moderna’s new bivalent Covid vaccine